A deep analysis of Ursodeoxycholic Acid (UDCA) therapeutics, global clinical demands, and the critical import requirements under the CE certification regime.
Over the last decade, the global market for biliary acids has transitioned from small-scale natural animal extraction to large-scale chemical and enzymatic synthesis. Because natural UDCA from bear bile is highly restricted and ethically non-viable, modern pharmaceutical manufacturers rely exclusively on high-purity synthetic UDCA. Modern industrial synthesis starting from cholic acid derived from bovine sources or plant-based raw materials requires precise isomerization of the 7-alpha hydroxyl group to the beta position.
International buyers, particularly in Europe, now strictly require active pharmaceutical ingredients (APIs) to hold CE (Conformité Européenne) declarations, CEP (Certificate of Suitability to the Monographs of the European Pharmacopoeia), and active Drug Master Files (DMF). This regulatory structure guarantees that chemical synthesis processes control critical impurities such as lithocholic acid (a toxic hepatotoxic byproduct of cholic acid synthesis) to levels below 0.1% using HPLC validation.
UDCA is being studied for its neuroprotective capabilities in neurodegenerative diseases like Parkinson’s and Alzheimer's, driving future API market growth by an estimated CAGR of 6.8% through 2030.
Biotechnology companies are migrating from harsh chemical oxidation steps to eco-friendly multi-enzyme cascade processes, lowering production footprints and hazardous solvent residues.
Global regulatory bodies are enforcing stricter limits on individual unknown impurities, requiring pharmaceutical manufacturers to implement online automation and continuous crystallization technology.
Chengdu ChenLv Herb Co., Ltd. (referred to as "Chenlv Herb") was established in 2012 as a leading high-tech enterprise specializing in the R&D, production, and sales of high-quality botanical extracts and natural pharmaceutical ingredients. Committed to providing high-purity, highly active, and premium-grade raw materials, Chenlv Herb serves diverse industries globally including pharmaceuticals, health supplements, functional foods, and cosmetics.
With a focus on green, sustainable, and highly compliant chemical and biological processes, our facility aligns with strict cGMP guidelines. We leverage state-of-the-art analytical equipment (such as HPLC, GC, LC-MS) to ensure every batch of API and plant extract exceeds international quality thresholds.
Established In
Driven by science, verified by clinical compliance.
Choose Chenlv Herb for premium quality APIs and natural compounds that consistently exceed expectations.
Creative designs and proprietary extraction processes that elevate your brand and establish therapeutic differentiation in the market.
Eco-friendly packaging and lean extraction operations aligned with today's environmental standards and fast lead-time demands.
Comprehensive natural ingredient sourcing and solvent-free processing methods that protect the environment and end-users.
Dedicated technical and regulatory specialists to ensure quick turnaround times, smooth custom synthesis, and fast customs clearance.
A rigorous multi-tiered quality control system ensuring precision compliance with USP, EP, and local food-grade/pharma-grade regulations.
Over a decade of deep chemical synthesis and biological extraction experience, providing clients with unparalleled product consistency.
Understanding key price drivers for Ursodeoxycholic Acid, including purities, structural crystallization forms, regulatory compliance documentation, and order volumes.
The pricing structure of UDCA API depends heavily on regulatory documentation, purity specifications, and geographical shipping demands. The table below represents a strategic pricing framework based on quality grade and certification requirements for global bulk procurement.
| API Purity Grade | Crystallization Structure | Certifications Included | Packaging Specs | Target Price Bracket (USD/kg) | Lead Time & Sourcing Mode |
|---|---|---|---|---|---|
| UDCA USP / EP Grade >99% | Form Alpha (Anhydrous Crystalline) | CE, GMP, FDA DMF, CEP | 25kg Poly-lined Fiber Drums | $180 - $220 (bulk contract) | 15 - 20 Days / Air or Sea Freight |
| Micronized UDCA API (D90 <10μm) | Enhanced Dissolution Crystalline | CE, GMP, ISO9001 | 10kg / 25kg Drums | $210 - $250 | 20 - 25 Days / Custom Particle Size |
| Bile Acid Blend (Custom OEM formulation) | Co-precipitate / Granular | ISO22000, HALAL, KOSHER | Custom Bags or Drums | $140 - $170 (depending on ratio) | 30 Days / Formulation Development |
| Standard Research Grade >98% | Amorphous / Crystalline Powder | COA, MSDS, ISO9001 | 1kg / 5kg Foils | $120 - $150 | Immediate Dispatch |
Price fluctuations are highly sensitive to raw material availability (namely cholic acid or deoxycholic acid derived from poultry/cattle slaughter industry byproducts) and environmental safety controls in synthesis regions. Purchasing managers should secure rolling 12-month supply-chain contracts to insulate their downstream production costs from seasonal commodity market variations.
Our plant extracts and pharmaceutical ingredients are optimized to drive product differentiation and efficacy across four primary vertical markets.
Driven by the concept of "homology of medicine and food" and modern health needs, natural extracts have become core raw materials for health supplements due to their natural, green, and safe characteristics.
READ MORE →
From herbal formulas recorded in ancient books to modern innovative drugs, plant extracts and bile acids occupy prominent positions in the pharmaceutical industry due to their highly targeted active pharmacological effects.
READ MORE →
With consumers' pursuit of natural and sustainable skincare, plant extracts have become favorites in the cosmetics industry due to their mildness, versatility, biocompatibility, and skin-barrier protection.
READ MORE →
Bile acids and plant extracts show tremendous potential in improving liver protection, enhancing lipid digestibility, and optimizing gut-microbiome benefits, serving as hotspots in animal health nutrition.
READ MORE →Chenlv Herb provides full-service, one-stop contract manufacturing and supply solutions from requirement gathering to safe international logistics.
We consult directly with your technical team to define active compound parameters, required purity, and testing specifications.
We provide a comprehensive, transparent price list and logistical proposal customized to your shipping destination and volume needs.
We establish formal commercial and quality agreements, delineating strict compliance requirements, NDAs, and production dates.
Our lab designs trial batches, optimizing characteristics such as particle size, density, solubility, and molecular morphology.
Upon sample validation, we scale up production in our ISO-certified GMP workshop, closely monitoring reaction kinetics and yields.
Our quality department runs intensive testing (NMR, ICP-MS, Bio-burden analysis) to release the certified batch and issue the official COA.
We secure appropriate hazardous/non-hazardous transport packaging and ship the finished products with full tracking records.
Pioneering green biotechnology processes to lower production costs, eliminate animal testing, and satisfy the EU Green Deal compliance policies.
During chemical synthesis, the epimerization of chenodeoxycholic acid to ursodeoxycholic acid occasionally leaves traces of lithocholic acid (LCA), which is cytotoxic and hepatotoxic. Our technical roadmap focuses on developing immobilized enzymes (such as 7α- and 7β-hydroxysteroid dehydrogenases) that operate at mild temperatures and ambient pressures, converting intermediates with over 99.8% conversion selectivity. This ensures zero formation of structural isomers or toxic byproducts, setting a new industry standard.
To safeguard against global supply chain shocks, we are reinforcing our localized documentation assistance. By providing European clients with pre-screened CEP registration dossiers, we drastically reduce registration lead times with the EDQM (European Directorate for the Quality of Medicines).
Our company and production facilities are strictly certified by ISO9001, ISO22000, HALAL, KOSHER, FDA, and European quality guidelines.
We integrate research, development, state-of-the-art manufacturing, and global pharmaceutical networking events.
Recently, the market price of Citrus aurantium raw materials in China has been on the rise, drawing significant attention from the industry. As the new production season (May-June) comes to an end and new supplies gradually enter the market, price fluctuations have become a focal point due to supply and demand dynamics and cost considerations.
As a 'calling card' for leading China's pharmaceutical industry onto the global stage, the 23rd China Pharmaceutical Raw Materials Exhibition (CPHI China 2025) will join hands with the 18th China Pharmaceutical Machinery.
Connect with our engineering and procurement team directly at the upcoming conference to finalize contract volumes, inspect raw data sheets, and secure your long-term supply quotas.
For direct technical inquiries about our certified active pharmaceutical ingredients, custom extraction capabilities, or our updated bulk pricelist, please enter your contact info. Our technical sales team will reply within 24 hours.
In-depth answers mapping to the core query intents of pharmaceutical buyers, quality managers, and regulatory consultants.
